Tandem Diabetes Care to acquire AMF Medical for approximately $216 million

AMF is a developer and manufacturer of insulin patch pumps. The Sigi patch pump developed by AMF includes gel pads and insulin pumps that stick to the skin. Paired with AMF’s one-touch applicator, the Sigi patch pump can be easily clicked off and on for cartridge recharging and refilling. Users receive two pumps and USB chargers in the Sigi starter kit, which can be recharged and refilled as needed, enabling uninterrupted insulin delivery. Each pump has a service life of several years. The Sigi patch pump connects via Bluetooth to continuous glucose monitoring devices, smartphones and other dedicated controllers, easily integrating into a user’s existing diabetes management regimen. Tandem Diabetes Care announced plans to acquire insulin pump company AMF Medical in a deal valued at CHF 200 million, or approximately $216 million.

This article is transferred from: https://www.itjuzi.com/merger/9553
This site is only for collection, and the copyright belongs to the original author.